Moreover, the mechanistic target of the rapamycin (mTOR) inhibitor, temsirolimus, has been found to directly bind and inhibit FSP1 activity, thereby inducing ferroptosis in liver cancer cells. The gene discussed is AIFM2; the disease is liver cancer.